Status:
COMPLETED
Evaluation of mHealth for Serious Mental Illness
Lead Sponsor:
University of Washington
Conditions:
Schizophrenia
Schizoaffective Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is a waitlist control trial evaluating the acceptability and preliminary efficacy of a smartphone application with people with mental illness.
Eligibility Criteria
Inclusion
- 18 years or older
- Owns an Android or iPhone smartphone with WiFi or 3G/4G capabilities (required for data transmission)
- Has diagnosis of Schizophrenia, Schizoaffective Disorder, Bipolar Disorder or Major Depression
- English speaker
Exclusion
- Does not live in the U.S.
- Has already participated in the study
- Unavailable for 60 days
- Currently incarcerated or hospitalized
Key Trial Info
Start Date :
January 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2021
Estimated Enrollment :
315 Patients enrolled
Trial Details
Trial ID
NCT04068467
Start Date
January 6 2020
End Date
May 1 2021
Last Update
August 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Washington
Seattle, Washington, United States, 98195